Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery
Molecules · 05.12.2024 · 29 (23) · 5748
DOI: 10.3390/molecules29235748 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 05.12.2024. Verfasst von Qingxin Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Engineering Laboratory of Biomass High Value Utilization, Institute of Biological and Medical Engineering, Guangdong Academy of …. Hauptthemen laut MEDLINE: Drug Discovery, Fluorine, Magnetic Resonance Spectroscopy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Hundred-Talent Program”, Guangdong Academy of Sciences, GDAS’ Project of Science and Technology Development.
Abstract (Originalsprache)
Fragment-based drug discovery is a powerful approach in drug discovery, applicable to a wide range of targets. This method enables the discovery of potent compounds that can modulate target functions, starting from fragment compounds that bind weakly to the targets. While biochemical, biophysical, and cell-based assays are commonly used to identify fragments, 19F-NMR spectroscopy has emerged as a powerful tool for exploring interactions between biomolecules and ligands. Because fluorine atoms are not naturally present in biological systems, 19F-NMR serves as a sensitive method for fragment screening against diverse targets. Herein, we reviewed the applications of 19F-NMR in fragment screening, highlighting its effectiveness in identifying fragments that bind weakly to various targets such as proteins and RNA. The accumulated evidence suggests that 19F-NMR will continue to be a crucial tool in drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Engineering Laboratory of Biomass High Value Utilization, Institute of Biological and Medical Engineering, Guangdong Academy of Sciences, Guangzhou 510316, China.
- Experimental Drug Development Centre (EDDC), Agency for Science, Technology and Research (A*STAR), 10 Biopolis Road, #05-01, Singapore 138670, Singapore.
ORCID-Profile: Qingxin Li, CongBao Kang
Förderung
- “Hundred-Talent Program”
- Guangdong Academy of Sciences, GDAS’ Project of Science and Technology Development
Zitieren
APA
Li, Q., & Kang, C. (2024). Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery. Molecules, 29(23), 5748. https://doi.org/10.3390/molecules29235748
Vancouver
Li Q, Kang C. Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery. Molecules. 2024;29(23):5748. doi:10.3390/molecules29235748
BibTeX
@article{Li2024,
author = {Li, Qingxin and Kang, CongBao},
title = {Perspectives on Applications of 19F-NMR in Fragment-Based Drug Discovery},
journal = {Molecules},
year = {2024},
volume = {29},
number = {23},
pages = {5748},
doi = {10.3390/molecules29235748}
}
EUVIMED